What is the Quantamatrix Inc. stock price forecast?

Quantamatrix Inc. is currently trading at ₩2,825. View real-time AI analysis on Alpha Lenz.

What is Quantamatrix Inc. insider trading activity?

View the latest insider trading data for Quantamatrix Inc. on Alpha Lenz.

What is Quantamatrix Inc.'s P/E ratio?

Quantamatrix Inc.'s P/E ratio is -3.0.

Quantamatrix Inc.

KRX · 317690

₩2,825-110(-3.75%)Market closed

Ask about Quantamatrix Inc.'s future dividend policy...

Alpha Chat Insight

“Quantamatrix Inc. trades at a P/E of -3.0 (undervalued) with modest ROE of -83.6%. 3Y revenue CAGR of 42.1% highlights clear growth momentum.”

Ask for details →

Company Overview

Quantamatrix Inc. is a biotechnology company that focuses on developing and commercializing groundbreaking diagnostic technologies and products. With an emphasis on rapid and accurate diagnostic solutions, Quantamatrix aims to advance the field of medical diagnostics through innovations that enhance the speed and reliability of pathogen detection. The company's flagship products are built around technologies that provide quick results and are invaluable in settings that require urgent medical decision-making, such as hospitals and clinics. Serving both healthcare providers and laboratory markets, Quantamatrix is instrumental in improving patient outcomes and optimizing treatment strategies. The company's commitment to quality and innovation positions it as a significant player in the biotechnology sector, contributing to enhanced healthcare delivery and efficiency across global medical landscapes.

CEO권성훈

Websitehttps://www.quantamatrix.com

SectorHealthcare

IndustryMedical Devices

Employees91

Company Statistics

FY 2025

Profile

₩59,096,310,115Market Cap

₩3,688,305,340Revenue

20.14MShares Out

91Employees

Margins

43.72%Gross

-377.88%EBITDA

-421.98%Operating

-527.63%Pre-Tax

-527.63%Net

Valuation

-3.04P/E

1.48P/B

16.02EV/Sales

-2.16EV/EBITDA

-3.75P/FCF

Growth (CAGR)

42.08%Rev 3Yr

16.90%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-48.96%ROA

-83.64%ROE

-44.82%ROIC

Financial Health

₩38,541,079,210Cash & Cash Equivalents

₩-25,874,097,960Net Debt

31.66%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Quantamatrix Inc. trades at a P/E of -3.0 (undervalued) with modest ROE of -83.6%. 3Y revenue CAGR of 42.1% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Quantamatrix Inc. (ticker: 317690) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 91 employees. Market cap is $59.1B.

The current price is ₩2,825 with a P/E ratio of -3.04x and P/B of 1.48x.

ROE is -83.64% and operating margin is -421.98%. Annual revenue is $3.7B.